retatrutide clinical trial effects Retatrutide, an experimental drug currently in Phase 3 trials, is nicknamed the Godzilla of weight-loss jabs because of its potential superior efficacy. Developed by Eli Lilly, is a triple hormone ESC 2024: Retatrutide improves lipid

But now, theyre widely prescribed for those with obesity or weight-related health conditions (even if diabetes isnt part of the picture)

The effect of glucagon-like peptide-1 receptor agonists on cardiac function and structure in patients with or without type 2 diabetes mellitus: an updated systematic review and meta-analysis

The Conservative Futurist: How To Create the Sci-Fi World We Were Promised is currently available for pre-order pretty much everywhere

Remember, temporary nausea, bloating, or changes in bowel habits are common and expectedbut if anything feels severe, contact your HealthiCare clinician

ADM prescribing in September 2025 increased slightly compared to June 2025 (+5.2%)